BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10925303)

  • 1. TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase.
    Dri P; Gasparini C; Menegazzi R; Cramer R; Albéri L; Presani G; Garbisa S; Patriarca P
    J Immunol; 2000 Aug; 165(4):2165-72. PubMed ID: 10925303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that elastase is the TNF-R75 shedding enzyme in resting human polymorphonuclear leukocytes.
    Gasparini C; Menegazzi R; Patriarca P; Dri P
    FEBS Lett; 2003 Oct; 553(3):360-4. PubMed ID: 14572651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-induced superoxide anion production in adherent human neutrophils involves both the p55 and p75 TNF receptor.
    Richter J; Gullberg U; Lantz M
    J Immunol; 1995 Apr; 154(8):4142-9. PubMed ID: 7706751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the 75-kDa TNF receptor in TNF-induced activation of neutrophil respiratory burst.
    Dri P; Haas E; Cramer R; Menegazzi R; Gasparini C; Martinelli R; Scheurich P; Patriarca P
    J Immunol; 1999 Jan; 162(1):460-6. PubMed ID: 9886420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to endothelial cells induces release of soluble tumor necrosis factor (TNF) receptor forms from neutrophil granulocytes.
    Björnberg F; Lantz M
    Biochem Biophys Res Commun; 1998 Mar; 244(2):594-8. PubMed ID: 9514954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms.
    Lantz M; Björnberg F; Olsson I; Richter J
    J Immunol; 1994 Feb; 152(3):1362-9. PubMed ID: 7905502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha.
    Alaaeddine N; DiBattista JA; Pelletier JP; Cloutier JM; Kiansa K; Dupuis M; Martel-Pelletier J
    J Rheumatol; 1997 Oct; 24(10):1985-94. PubMed ID: 9330943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA; Steer JH
    J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
    Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S
    Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75.
    Declercq W; Denecker G; Fiers W; Vandenabeele P
    J Immunol; 1998 Jul; 161(1):390-9. PubMed ID: 9647248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers.
    Alsalameh S; Winter K; Al-Ward R; Wendler J; Kalden JR; Kinne RW
    Scand J Immunol; 1999 Mar; 49(3):278-85. PubMed ID: 10102645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
    Zhang Z; Oliver P; Lancaster JR; Schwarzenberger PO; Joshi MS; Cork J; Kolls JK
    FASEB J; 2001 Feb; 15(2):303-5. PubMed ID: 11156944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha and FMLP receptors are functionally linked during FMLP-stimulated activation of adherent human neutrophils.
    Balazovich KJ; Suchard SJ; Remick DG; Boxer LA
    Blood; 1996 Jul; 88(2):690-6. PubMed ID: 8695817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation.
    Mackay F; Rothe J; Bluethmann H; Loetscher H; Lesslauer W
    J Immunol; 1994 Dec; 153(11):5274-84. PubMed ID: 7525730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.
    Bohlson SS; Silva R; Fonseca MI; Tenner AJ
    J Immunol; 2005 Jul; 175(2):1239-47. PubMed ID: 16002728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
    Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
    J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF; Dentener MA; Buurman WA
    J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
    Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW
    Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.